Dermatophytic Onychomycosis Treatment Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2029

13.38%
CAGR (2023-2029)
4.29 USD Bn.
Market Size
325
Report Pages
165
Market Tables

Overview

Dermatophytic Onychomycosis Treatment Market was valued at US$ 4.29 Bn in 2022 and is expected to reach US$ 10.34 Bn by 2029 at a CAGR of 13.38%.

Dermatophytic Onychomycosis Treatment Market Dynamics

The Dermatophytic onychomycosis also called as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails. Trichophyton mentagrophytes and Trichophyton rubrum are mutual strains of fungi responsible for causing dermatophytic onychomycosis.

Major factors influencing the dermatophytic onychomycosis treatment market growth are consistently increasing the prevalence of onychomycosis infections worldwide along with the development of novel medications available commercially for the treatment of onychomycosis infections. Moreover, consistent rise in a geriatric population who are highly susceptible to acquiring the infections along with a rising in treatment rate due to increasing socialization of the individuals are some of the features that would further drive the dermatophytic onychomycosis infections therapeutics market.Dermatophytic Onychomycosis Treatment MarketTo know about the Research Methodology:-Request Free Sample Report

Dermatophytic Onychomycosis Treatment Segment Analysis

The nail paint segment based on production is expected to contribute a larger share to the dermatophytic onychomycosis therapeutics market globally. Nail fungus can be very persistent. Topical treatment with nail polish could take up to one year. Tablets for treating fungal nail infections generally have to be taken for several weeks or months. They are very effective than topical treatments, but they have more side effects.

Drug stores are dominating the global dermatophytic onychomycosis treatment market. The drug stores segment is expected to register the highest CAGR during the forecast period. Independent pharmacies are anticipated to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2022 end.
New and developing approaches to treat dermatophytic onychomycosis are device-based laser and photodynamic therapy. Many companies have targeted this approach to provide an effective cure for dermatophytic onychomycosis. In 2017, the FDA approved Erchonia’s Lunula laser device, which provides low-level laser therapy to treat nail onychomycosis treatment.

Regional insights

Region-wise, North America is projected to hold a dominant position in the dermatophytic onychomycosis treatment market globally, followed by Europe, due to the high prevalence of dermatophytic onychomycosis and the increasing geriatric population in the U.S. According to the Centre for Disease Control and Prevention in 2022, nail fungus or dermatophytic onychomycosis affects around 26 million people in the U.S. each year.
Global dermatophytic onychomycosis treatment market report includes PESTLE analysis, competitive landscape, and Porter’s five force model. Market attractive analysis wherein all the segments are benchmarked based on the market size, growth rate, and general attractiveness.

Key players are launching innovative products in the dermatophytic onychomycosis treatment market globally, in order to expand their market footprint, addressing the limitations of current therapeutics to give dermatophytic onychomycosis. In 2014, Valeant Pharmaceuticals was granted with Food and Drug Administration (FDA) agreement for its topical product for dermatophytic onychomycosis named Efinaconazole.

Dermatophytic Onychomycosis Treatment Marke, Key Highlights:

Global Dermatophytic Onychomycosis Treatment Marke analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Dermatophytic Onychomycosis Treatment Market

Global Dermatophytic Onychomycosis Treatment Marke segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

The Global Dermatophytic Onychomycosis Treatment Marke strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Dermatophytic Onychomycosis Treatment Marke analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Dermatophytic Onychomycosis Treatment Marke are also profiled.

Dermatophytic Onychomycosis Treatment Market Scope: Inquire before buying

Dermatophytic Onychomycosis Treatment Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.29 Bn.
Forecast Period 2023 to 2029 CAGR: 13.38% Market Size in 2029: US $ 10.34 Bn.
Segments Covered: by Product Nail Paint
Tablet

Prescription Tablets
Over-the-Counter (OTC) Tablets
by Route of administration Topical
Oral Therapy
by End-User Hospitals
Dermatology & Podiatry Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores

by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Dermatophytic Onychomycosis Treatment Market, Key Players

1. Bausch Health Companies
2. Galderma S.A.
3. Celtic Pharma
4. Anacor pharmaceuticals, Inc.
5. Johnson & Johnson
6. Novartis AG
7. Pfizer Inc.
8. GlaxoSmithKline
9. Topica Pharmaceuticals, Inc.
10.Moberg Pharma AB
11.Bayer AG
12.Dr. Reddy’s Laboratories Ltd
13.Allergen, Inc.
14.Cipla Ltd
15.Medimetriks Pharmaceuticals Inc.
16.Sanofi S.A.
17.NovaBiotics Inc.
18.Merz Pharma.

Frequently Asked Questions:

1. Which region has the largest share in Dermatophytic Onychomycosis Treatment Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Dermatophytic Onychomycosis Treatment Market?
Ans: The global market is growing at a CAGR of 13.38% during forecasting period 2023-2029.

3. What is scope of the Global Dermatophytic Onychomycosis Treatment market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Dermatophytic Onychomycosis Treatment market?
Ans: The important key players in the global market are – Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma.

5. What is the study period of this market?
Ans: The Global Dermatophytic Onychomycosis Treatment Market is studied from 2022 to 2029.

Table of Contents

Dermatophytic Onychomycosis Treatment Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Dermatophytic Onychomycosis Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Challenges 4.2.4. Emerging Technology 4.2.5. Opportunities 4.3. Market Analysis 4.3.1. Porter’s Analysis 4.3.2. Value Chain Analysis 4.3.3. Pricing Analysis 4.3.4. Market Risk analysis 4.3.5.Key Trends in Global Dermatophytic Onychomycosis Treatment Market 5. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast 5.1. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast 5.2. Global Dermatophytic Onychomycosis Treatment Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. South America 6. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 6.3. Market Size (US$ Bn) Forecast, by Product 6.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Product 6.5. Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Product 7. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by Route of Administration 7.1. Introduction and Definition 7.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 7.3. Market Size (US$ Bn) Forecast, by Route of Administration 7.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Route of Administration 7.5. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Route of Administration 8. Global Dermatophytic Onychomycosis Treatment Market Analysis and Forecast, by End user 8.1. Introduction and Definition 8.2. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 8.3. Market Size (US$ Bn) Forecast, by End user 8.4. Global Dermatophytic Onychomycosis Treatment Market Analysis, by End user 8.5. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by End user 9. Global Dermatophytic Onychomycosis Treatment Market Analysis, by Region 9.1. Global Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Region 9.2. Market Size (US$ Bn) Forecast, by Region 9.3. Global Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis, by Region 10. North America Dermatophytic Onychomycosis Treatment Market Analysis 10.1. North America Dermatophytic Onychomycosis Treatment Market Overview 10.2. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 10.3. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Product 10.3.1. Nail Paint 10.3.2. Tablet 10.3.2.1. Prescription Tablets 10.3.2.2. Over-the-Counter (OTC) Tablets 10.4. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 10.5. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 10.5.1. Topical 10.5.2. Oral Therapy 10.6. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 10.7. North America Dermatophytic Onychomycosis Treatment Market Forecast, by End user 10.7.1. Hospitals 10.7.2. Dermatology & Podiatry Clinics 10.7.3. Independent Pharmacies 10.7.4. Mail Order Pharmacies 10.7.5. Drug Stores 10.8. North America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country 10.9. North America Dermatophytic Onychomycosis Treatment Market Forecast, by Country 10.9.1. U.S 10.9.2. Canada 10.10. North America Dermatophytic Onychomycosis Treatment Market Analysis, by Country 10.11. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by Product 10.11.1. Nail Paint 10.11.2. Tablet 10.11.2.1. Prescription Tablets 10.11.2.2. Over-the-Counter (OTC) Tablets 10.12. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 10.12.1. Topical 10.12.2. Oral Therapy 10.13. U.S. Dermatophytic Onychomycosis Treatment Market Forecast, by End user 10.13.1. Hospitals 10.13.2. Dermatology & Podiatry Clinics 10.13.3. Independent Pharmacies 10.13.4. Mail Order Pharmacies 10.13.5. Drug Stores 10.14. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by Product 10.14.1. Nail Paint 10.14.2. Tablet 10.14.2.1. Prescription Tablets 10.14.2.2. Over-the-Counter (OTC) Tablets 10.15. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 10.15.1. Topical 10.15.2. Oral Therapy 10.16. Canada Dermatophytic Onychomycosis Treatment Market Forecast, by End user 10.16.1. Hospitals 10.16.2. Dermatology & Podiatry Clinics 10.16.3. Independent Pharmacies 10.16.4. Mail Order Pharmacies 10.16.5. Drug Stores 10.17. North America Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis 10.17.1. by Product 10.17.2. by Route of Administration 10.17.3. by End user 10.18. PEST Analysis 10.19. Key Trends 10.20. Key Developments 11. Europe Dermatophytic Onychomycosis Treatment Market Analysis 11.1. Europe Dermatophytic Onychomycosis Treatment Market Overview 11.2. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 11.3. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.3.1. Nail Paint 11.3.2. Tablet 11.3.2.1. Prescription Tablets 11.3.2.2. Over-the-Counter (OTC) Tablets 11.4. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 11.5. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.5.1. Topical 11.5.2. Oral Therapy 11.6. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 11.7. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.7.1. Hospitals 11.7.2. Dermatology & Podiatry Clinics 11.7.3. Independent Pharmacies 11.7.4. Mail Order Pharmacies 11.7.5. Drug Stores 11.8. Europe Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country 11.9. Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Country 11.9.1. Germany 11.9.2. U.K. 11.9.3. France 11.9.4. Italy 11.9.5. Spain 11.9.6. Rest of Europe 11.10. Europe Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region 11.11. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.11.1. Nail Paint 11.11.2. Tablet 11.11.2.1. Prescription Tablets 11.11.2.2. Over-the-Counter (OTC) Tablets 11.12. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.12.1. Topical 11.12.2. Oral Therapy 11.13. Germany Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.13.1. Hospitals 11.13.2. Dermatology & Podiatry Clinics 11.13.3. Independent Pharmacies 11.13.4. Mail Order Pharmacies 11.13.5. Drug Stores 11.14. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.14.1. Nail Paint 11.14.2. Tablet 11.14.2.1. Prescription Tablets 11.14.2.2. Over-the-Counter (OTC) Tablets 11.15. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.15.1. Topical 11.15.2. Oral Therapy 11.16. U.K. Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.16.1. Hospitals 11.16.2. Dermatology & Podiatry Clinics 11.16.3. Independent Pharmacies 11.16.4. Mail Order Pharmacies 11.16.5. Drug Stores 11.17. France Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.17.1. Nail Paint 11.17.2. Tablet 11.17.2.1. Prescription Tablets 11.17.2.2. Over-the-Counter (OTC) Tablets 11.18. France Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.18.1. Topical 11.18.2. Oral Therapy 11.19. France Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.19.1. Hospitals 11.19.2. Dermatology & Podiatry Clinics 11.19.3. Independent Pharmacies 11.19.4. Mail Order Pharmacies 11.19.5. Drug Stores 11.20. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.20.1. Nail Paint 11.20.2. Tablet 11.20.2.1. Prescription Tablets 11.20.2.2. Over-the-Counter (OTC) Tablets 11.21. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.21.1. Topical 11.21.2. Oral Therapy 11.22. Italy Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.22.1. Hospitals 11.22.2. Dermatology & Podiatry Clinics 11.22.3. Independent Pharmacies 11.22.4. Mail Order Pharmacies 11.22.5. Drug Stores 11.23. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.23.1. Nail Paint 11.23.2. Tablet 11.23.2.1. Prescription Tablets 11.23.2.2. Over-the-Counter (OTC) Tablets 11.24. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.24.1. Topical 11.24.2. Oral Therapy 11.25. Spain Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.25.1. Hospitals 11.25.2. Dermatology & Podiatry Clinics 11.25.3. Independent Pharmacies 11.25.4. Mail Order Pharmacies 11.25.5. Drug Stores 11.26. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Product 11.26.1. Nail Paint 11.26.2. Tablet 11.26.2.1. Prescription Tablets 11.26.2.2. Over-the-Counter (OTC) Tablets 11.27. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 11.27.1. Topical 11.27.2. Oral Therapy 11.28. Rest of Europe Dermatophytic Onychomycosis Treatment Market Forecast, by End user 11.28.1. Hospitals 11.28.2. Dermatology & Podiatry Clinics 11.28.3. Independent Pharmacies 11.28.4. Mail Order Pharmacies 11.28.5. Drug Stores 11.29. Europe Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis 11.29.1. by Product 11.29.2. by Route of Administration 11.29.3. by End user 11.30. PEST Analysis 11.31. Key Trends 11.32. Key Developments 12. Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis 12.1. Asia Pacific Dermatophytic Onychomycosis Treatment Market Overview 12.2. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 12.3. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.3.1. Nail Paint 12.3.2. Tablet 12.3.2.1. Prescription Tablets 12.3.2.2. Over-the-Counter (OTC) Tablets 12.4. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 12.5. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.5.1. Topical 12.5.2. Oral Therapy 12.6. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 12.7. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.7.1. Hospitals 12.7.2. Dermatology & Podiatry Clinics 12.7.3. Independent Pharmacies 12.7.4. Mail Order Pharmacies 12.7.5. Drug Stores 12.8. Asia Pacific Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country 12.9. Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Country 12.9.1. China 12.9.2. India 12.9.3. Japan 12.9.4. ASEAN 12.9.5. Rest of Asia Pacific 12.10. Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region 12.11. China Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.11.1. Nail Paint 12.11.2. Tablet 12.11.2.1. Prescription Tablets 12.11.2.2. Over-the-Counter (OTC) Tablets 12.12. China Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.12.1. Topical 12.12.2. Oral Therapy 12.13. China Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.13.1. Hospitals 12.13.2. Dermatology & Podiatry Clinics 12.13.3. Independent Pharmacies 12.13.4. Mail Order Pharmacies 12.13.5. Drug Stores 12.14. India Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.14.1. Nail Paint 12.14.2. Tablet 12.14.2.1. Prescription Tablets 12.14.2.2. Over-the-Counter (OTC) Tablets 12.15. India Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.15.1. Topical 12.15.2. Oral Therapy 12.16. India Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.16.1. Hospitals 12.16.2. Dermatology & Podiatry Clinics 12.16.3. Independent Pharmacies 12.16.4. Mail Order Pharmacies 12.16.5. Drug Stores 12.17. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.17.1. Nail Paint 12.17.2. Tablet 12.17.2.1. Prescription Tablets 12.17.2.2. Over-the-Counter (OTC) Tablets 12.18. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.18.1. Topical 12.18.2. Oral Therapy 12.19. Japan Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.19.1. Hospitals 12.19.2. Dermatology & Podiatry Clinics 12.19.3. Independent Pharmacies 12.19.4. Mail Order Pharmacies 12.19.5. Drug Stores 12.20. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.20.1. Nail Paint 12.20.2. Tablet 12.20.2.1. Prescription Tablets 12.20.2.2. Over-the-Counter (OTC) Tablets 12.21. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.21.1. Topical 12.21.2. Oral Therapy 12.22. ASEAN Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.22.1. Hospitals 12.22.2. Dermatology & Podiatry Clinics 12.22.3. Independent Pharmacies 12.22.4. Mail Order Pharmacies 12.22.5. Drug Stores 12.23. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Product 12.23.1. Nail Paint 12.23.2. Tablet 12.23.2.1. Prescription Tablets 12.23.2.2. Over-the-Counter (OTC) Tablets 12.24. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 12.24.1. Topical 12.24.2. Oral Therapy 12.25. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market Forecast, by End user 12.25.1. Hospitals 12.25.2. Dermatology & Podiatry Clinics 12.25.3. Independent Pharmacies 12.25.4. Mail Order Pharmacies 12.25.5. Drug Stores 12.26. Asia Pacific Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis 12.26.1. by Product 12.26.2. by Route of Administration 12.26.3. by End user 12.27. PEST Analysis 12.28. Key Trends 12.29. Key Developments 13. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Analysis 13.1. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Overview 13.2. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 13.3. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product 13.3.1. Nail Paint 13.3.2. Tablet 13.3.2.1. Prescription Tablets 13.3.2.2. Over-the-Counter (OTC) Tablets 13.4. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 13.5. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 13.5.1. Topical 13.5.2. Oral Therapy 13.6. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 13.7. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user 13.7.1. Hospitals 13.7.2. Dermatology & Podiatry Clinics 13.7.3. Independent Pharmacies 13.7.4. Mail Order Pharmacies 13.7.5. Drug Stores 13.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country 13.9. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Country 13.9.1. GCC 13.9.2. South Africa 13.9.3. Rest of Middle East & Africa 13.10. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region 13.11. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by Product 13.11.1. Nail Paint 13.11.2. Tablet 13.11.2.1. Prescription Tablets 13.11.2.2. Over-the-Counter (OTC) Tablets 13.12. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 13.12.1. Topical 13.12.2. Oral Therapy 13.13. GCC Dermatophytic Onychomycosis Treatment Market Forecast, by End user 13.13.1. Hospitals 13.13.2. Dermatology & Podiatry Clinics 13.13.3. Independent Pharmacies 13.13.4. Mail Order Pharmacies 13.13.5. Drug Stores 13.14. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product 13.14.1. Nail Paint 13.14.2. Tablet 13.14.2.1. Prescription Tablets 13.14.2.2. Over-the-Counter (OTC) Tablets 13.15. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 13.15.1. Topical 13.15.2. Oral Therapy 13.16. South Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user 13.16.1. Hospitals 13.16.2. Dermatology & Podiatry Clinics 13.16.3. Independent Pharmacies 13.16.4. Mail Order Pharmacies 13.16.5. Drug Stores 13.17. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Product 13.17.1. Nail Paint 13.17.2. Tablet 13.17.2.1. Prescription Tablets 13.17.2.2. Over-the-Counter (OTC) Tablets 13.18. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 13.18.1. Topical 13.18.2. Oral Therapy 13.19. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market Forecast, by End user 13.19.1. Hospitals 13.19.2. Dermatology & Podiatry Clinics 13.19.3. Independent Pharmacies 13.19.4. Mail Order Pharmacies 13.19.5. Drug Stores 13.20. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis 13.20.1. by Product 13.20.2. by Route of Administration 13.20.3. by End user 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America Dermatophytic Onychomycosis Treatment Market Analysis 14.1. South America Dermatophytic Onychomycosis Treatment Market Overview 14.2. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Product 14.3. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Product 14.3.1. Nail Paint 14.3.2. Tablet 14.3.2.1. Prescription Tablets 14.3.2.2. Over-the-Counter (OTC) Tablets 14.4. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Route of Administration 14.5. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 14.5.1. Topical 14.5.2. Oral Therapy 14.6. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by End user 14.7. South America Dermatophytic Onychomycosis Treatment Market Forecast, by End user 14.7.1. Hospitals 14.7.2. Dermatology & Podiatry Clinics 14.7.3. Independent Pharmacies 14.7.4. Mail Order Pharmacies 14.7.5. Drug Stores 14.8. South America Dermatophytic Onychomycosis Treatment Market Value Share Analysis, by Country 14.9. South America Dermatophytic Onychomycosis Treatment Market Forecast, by Country 14.9.1. Brazil 14.9.2. Mexico 14.9.3. Rest of South America 14.10. South America Dermatophytic Onychomycosis Treatment Market Analysis, by Country/ Sub-region 14.11. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by Product 14.11.1. Nail Paint 14.11.2. Tablet 14.11.2.1. Prescription Tablets 14.11.2.2. Over-the-Counter (OTC) Tablets 14.12. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 14.12.1. Topical 14.12.2. Oral Therapy 14.13. Brazil Dermatophytic Onychomycosis Treatment Market Forecast, by End user 14.13.1. Hospitals 14.13.2. Dermatology & Podiatry Clinics 14.13.3. Independent Pharmacies 14.13.4. Mail Order Pharmacies 14.13.5. Drug Stores 14.14. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by Product 14.14.1. Nail Paint 14.14.2. Tablet 14.14.2.1. Prescription Tablets 14.14.2.2. Over-the-Counter (OTC) Tablets 14.15. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 14.15.1. Topical 14.15.2. Oral Therapy 14.16. Mexico Dermatophytic Onychomycosis Treatment Market Forecast, by End user 14.16.1. Hospitals 14.16.2. Dermatology & Podiatry Clinics 14.16.3. Independent Pharmacies 14.16.4. Mail Order Pharmacies 14.16.5. Drug Stores 14.17. Research centres Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by Product 14.17.1. Nail Paint 14.17.2. Tablet 14.17.2.1. Prescription Tablets 14.17.2.2. Over-the-Counter (OTC) Tablets 14.18. Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by Route of Administration 14.18.1. Topical 14.18.2. Oral Therapy 14.19. Rest of South America Dermatophytic Onychomycosis Treatment Market Forecast, by End user 14.19.1. Hospitals 14.19.2. Dermatology & Podiatry Clinics 14.19.3. Independent Pharmacies 14.19.4. Mail Order Pharmacies 14.19.5. Drug Stores 14.20. South America Dermatophytic Onychomycosis Treatment Market Attractiveness Analysis 14.20.1. by Product 14.20.2. by Route of Administration 14.20.3. by End user 14.21. PEST Analysis 14.22. Key Trends 14.23. Key Developments 15. Competitive Landscape 15.1. Market Share Analysis, by Key Players 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. Market Consolidation 15.2.2.1. M&A by regions, investment, applications 15.2.2.2. M&A Key Players, forward integration, backward integration 15.3. Company Profiles: Key Player 15.3.1. Bausch Health Companies 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Business Strategy 15.3.1.4. Recent Developments 15.3.1.5. Manufacturing Footprint 15.3.2. Galderma S.A. 15.3.3. Celtic Pharma 15.3.4. Anacor pharmaceuticals, Inc. 15.3.5. Johnson & Johnson 15.3.6. Novartis AG 15.3.7. Pfizer Inc. 15.3.8. GlaxoSmithKline 15.3.9. Topica Pharmaceuticals, Inc. 15.3.10. Moberg Pharma AB 15.3.11. Bayer AG 15.3.12. Dr. Reddy’s Laboratories Ltd 15.3.13. Allergen, Inc. 15.3.14. Cipla Ltd 15.3.15. Medimetriks Pharmaceuticals Inc. 15.3.16. Sanofi S.A. 15.3.17. NovaBiotics Inc. 15.3.18. Merz Pharma. 16. Primary Key Insights

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample